Chemotherapy Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: C45DBE054BA5EN
Market Monitor Global

Abstracts

Chemotherapy is the use of any drug to treat any disease. But to most people, the wordchemotherapy means drugs used for cancer treatment.

This report contains market size and forecasts of Chemotherapy Drug in Global, including the following market information:

Global Chemotherapy Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Chemotherapy Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antimetabolites Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Chemotherapy Drug include Pfizer, Eli Lilly, CELGENE, Bristol-Myers Squibb, Merck, GlaxoSmithKline, Novartis, Sanofi and Teva Pharmaceuticals Industries. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chemotherapy Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chemotherapy Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Chemotherapy Drug Market Segment Percentages, by Type, 2021 (%)

• Antimetabolites
• Plant Alkaloids
• Alkylating Agents
• Antitumor Antibiotics

Global Chemotherapy Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Chemotherapy Drug Market Segment Percentages, by Application, 2021 (%)

• Oral
• Intravenous

Global Chemotherapy Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Chemotherapy Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Chemotherapy Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Chemotherapy Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Eli Lilly
• CELGENE
• Bristol-Myers Squibb
• Merck
• GlaxoSmithKline
• Novartis
• Sanofi
• Teva Pharmaceuticals Industries

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Chemotherapy Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Chemotherapy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CHEMOTHERAPY DRUG OVERALL MARKET SIZE

2.1 Global Chemotherapy Drug Market Size: 2021 VS 2028
2.2 Global Chemotherapy Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Chemotherapy Drug Players in Global Market
3.2 Top Global Chemotherapy Drug Companies Ranked by Revenue
3.3 Global Chemotherapy Drug Revenue by Companies
3.4 Top 3 and Top 5 Chemotherapy Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Chemotherapy Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chemotherapy Drug Players in Global Market
  3.6.1 List of Global Tier 1 Chemotherapy Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Chemotherapy Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Chemotherapy Drug Market Size Markets, 2021 & 2028
  4.1.2 Antimetabolites
  4.1.3 Plant Alkaloids
  4.1.4 Alkylating Agents
  4.1.5 Antitumor Antibiotics
4.2 By Type - Global Chemotherapy Drug Revenue & Forecasts
  4.2.1 By Type - Global Chemotherapy Drug Revenue, 2017-2022
  4.2.2 By Type - Global Chemotherapy Drug Revenue, 2023-2028
  4.2.3 By Type - Global Chemotherapy Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Chemotherapy Drug Market Size, 2021 & 2028
  5.1.2 Oral
  5.1.3 Intravenous
5.2 By Application - Global Chemotherapy Drug Revenue & Forecasts
  5.2.1 By Application - Global Chemotherapy Drug Revenue, 2017-2022
  5.2.2 By Application - Global Chemotherapy Drug Revenue, 2023-2028
  5.2.3 By Application - Global Chemotherapy Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Chemotherapy Drug Market Size, 2021 & 2028
6.2 By Region - Global Chemotherapy Drug Revenue & Forecasts
  6.2.1 By Region - Global Chemotherapy Drug Revenue, 2017-2022
  6.2.2 By Region - Global Chemotherapy Drug Revenue, 2023-2028
  6.2.3 By Region - Global Chemotherapy Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Chemotherapy Drug Revenue, 2017-2028
  6.3.2 US Chemotherapy Drug Market Size, 2017-2028
  6.3.3 Canada Chemotherapy Drug Market Size, 2017-2028
  6.3.4 Mexico Chemotherapy Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Chemotherapy Drug Revenue, 2017-2028
  6.4.2 Germany Chemotherapy Drug Market Size, 2017-2028
  6.4.3 France Chemotherapy Drug Market Size, 2017-2028
  6.4.4 U.K. Chemotherapy Drug Market Size, 2017-2028
  6.4.5 Italy Chemotherapy Drug Market Size, 2017-2028
  6.4.6 Russia Chemotherapy Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Chemotherapy Drug Market Size, 2017-2028
  6.4.8 Benelux Chemotherapy Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Chemotherapy Drug Revenue, 2017-2028
  6.5.2 China Chemotherapy Drug Market Size, 2017-2028
  6.5.3 Japan Chemotherapy Drug Market Size, 2017-2028
  6.5.4 South Korea Chemotherapy Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Chemotherapy Drug Market Size, 2017-2028
  6.5.6 India Chemotherapy Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Chemotherapy Drug Revenue, 2017-2028
  6.6.2 Brazil Chemotherapy Drug Market Size, 2017-2028
  6.6.3 Argentina Chemotherapy Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Chemotherapy Drug Revenue, 2017-2028
  6.7.2 Turkey Chemotherapy Drug Market Size, 2017-2028
  6.7.3 Israel Chemotherapy Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Chemotherapy Drug Market Size, 2017-2028
  6.7.5 UAE Chemotherapy Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Chemotherapy Drug Major Product Offerings
  7.1.4 Pfizer Chemotherapy Drug Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Eli Lilly
  7.2.1 Eli Lilly Corporate Summary
  7.2.2 Eli Lilly Business Overview
  7.2.3 Eli Lilly Chemotherapy Drug Major Product Offerings
  7.2.4 Eli Lilly Chemotherapy Drug Revenue in Global Market (2017-2022)
  7.2.5 Eli Lilly Key News
7.3 CELGENE
  7.3.1 CELGENE Corporate Summary
  7.3.2 CELGENE Business Overview
  7.3.3 CELGENE Chemotherapy Drug Major Product Offerings
  7.3.4 CELGENE Chemotherapy Drug Revenue in Global Market (2017-2022)
  7.3.5 CELGENE Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Chemotherapy Drug Major Product Offerings
  7.4.4 Bristol-Myers Squibb Chemotherapy Drug Revenue in Global Market (2017-2022)
  7.4.5 Bristol-Myers Squibb Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Chemotherapy Drug Major Product Offerings
  7.5.4 Merck Chemotherapy Drug Revenue in Global Market (2017-2022)
  7.5.5 Merck Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Chemotherapy Drug Major Product Offerings
  7.6.4 GlaxoSmithKline Chemotherapy Drug Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Chemotherapy Drug Major Product Offerings
  7.7.4 Novartis Chemotherapy Drug Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News
7.8 Sanofi
  7.8.1 Sanofi Corporate Summary
  7.8.2 Sanofi Business Overview
  7.8.3 Sanofi Chemotherapy Drug Major Product Offerings
  7.8.4 Sanofi Chemotherapy Drug Revenue in Global Market (2017-2022)
  7.8.5 Sanofi Key News
7.9 Teva Pharmaceuticals Industries
  7.9.1 Teva Pharmaceuticals Industries Corporate Summary
  7.9.2 Teva Pharmaceuticals Industries Business Overview
  7.9.3 Teva Pharmaceuticals Industries Chemotherapy Drug Major Product Offerings
  7.9.4 Teva Pharmaceuticals Industries Chemotherapy Drug Revenue in Global Market (2017-2022)
  7.9.5 Teva Pharmaceuticals Industries Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Chemotherapy Drug Market Opportunities & Trends in Global Market
Table 2. Chemotherapy Drug Market Drivers in Global Market
Table 3. Chemotherapy Drug Market Restraints in Global Market
Table 4. Key Players of Chemotherapy Drug in Global Market
Table 5. Top Chemotherapy Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Chemotherapy Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Chemotherapy Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Chemotherapy Drug Product Type
Table 9. List of Global Tier 1 Chemotherapy Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chemotherapy Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chemotherapy Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Chemotherapy Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Chemotherapy Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Chemotherapy Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Chemotherapy Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Chemotherapy Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Chemotherapy Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Chemotherapy Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Chemotherapy Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Chemotherapy Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Chemotherapy Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Chemotherapy Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Chemotherapy Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Chemotherapy Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Chemotherapy Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Chemotherapy Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Chemotherapy Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Chemotherapy Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Chemotherapy Drug Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Chemotherapy Drug Product Offerings
Table 32. Pfizer Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
Table 33. Eli Lilly Corporate Summary
Table 34. Eli Lilly Chemotherapy Drug Product Offerings
Table 35. Eli Lilly Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
Table 36. CELGENE Corporate Summary
Table 37. CELGENE Chemotherapy Drug Product Offerings
Table 38. CELGENE Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Chemotherapy Drug Product Offerings
Table 41. Bristol-Myers Squibb Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Chemotherapy Drug Product Offerings
Table 44. Merck Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Chemotherapy Drug Product Offerings
Table 47. GlaxoSmithKline Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Chemotherapy Drug Product Offerings
Table 50. Novartis Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Chemotherapy Drug Product Offerings
Table 53. Sanofi Chemotherapy Drug Revenue (US$, Mn), (2017-2022)
Table 54. Teva Pharmaceuticals Industries Corporate Summary
Table 55. Teva Pharmaceuticals Industries Chemotherapy Drug Product Offerings
Table 56. Teva Pharmaceuticals Industries Chemotherapy Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Chemotherapy Drug Segment by Type in 2021
Figure 2. Chemotherapy Drug Segment by Application in 2021
Figure 3. Global Chemotherapy Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chemotherapy Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chemotherapy Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chemotherapy Drug Revenue in 2021
Figure 8. By Type - Global Chemotherapy Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Chemotherapy Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Chemotherapy Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Chemotherapy Drug Revenue Market Share, 2017-2028
Figure 12. US Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Chemotherapy Drug Revenue Market Share, 2017-2028
Figure 16. Germany Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Chemotherapy Drug Revenue Market Share, 2017-2028
Figure 24. China Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Chemotherapy Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Chemotherapy Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Chemotherapy Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eli Lilly Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. CELGENE Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Pharmaceuticals Industries Chemotherapy Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)